You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A Topical Non-steroidal Anti-inflammatory for Atopic Dermatitis
SBC: SIGNUM BIOSCIENCES, INC. Topic: NIAIDSUMMARY Atopic dermatitis is a chronic dermatological condition afflicting mostly infants and young childrenCurrent treatments are associated with a wide range of side effects therefore development of novel therapeutic agents that are efficacious and have an improved safety profile is neededAlthough disease etiology has yet to be fully understoodskin inflammation is known to be critically involved ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Kinetic Phenotype Discovery Informatics for Neurological Diseases
SBC: DRVISION TECHNOLOGIES LLC Topic: 101Project Summary Neurological disorders significantly outnumber diseases in other therapeutic areas and are growing in incidence faster than any other disease classesHoweverthe pharmaceutical industry has been unsuccessful in coming up with effective drugsA big factor in these failures has been a lack of adequate model systems for fundamental disease understanding affecting both diagnosis and treat ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Enabling point-of-care molecular diagnostics by developing an adaptive PCR instrument and on-demand kit reagents
SBC: BIOVENTURES, INC Topic: 172Because of its high sensitivitypolymerase chain reactionPCRis the gold standard for the diagnosis of many infectious diseasesbut generally only implemented in well equipped laboratoriesOne of the major roadblocks for expanding PCR to point of care markets is the lack of simplerobustsingle tube PCR designs which preserve its laboratory based high sensitivity and specificityIn this Fast Track STTR a ...
STTR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
ADDRESSING THE SLOW GROWTH RATE OF PROSTATE PDXS BY ELIMINATING LOGISTICAL BARRIERS THROUGH DEVELOPMENT OF CDX
SBC: Champions Oncology, Inc. Topic: NCIProstate cancer disproportionally impacts African American men This project creates a cohort of metastatic prostate cancer patient derived xenografts PDX models for the express purpose of supporting efforts to elucidate clinical and molecular differences in prostate cancer between ethnic groups A cohort of up to metastatic prostate xenograft models will be generated using patient tissues an ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Development of Chemistry, Manufacturing, and Control Standards for PGC and PGC-dANP
SBC: PHARMAIN CORPORATION Topic: NHLBIABSTRACTThis application is seeking funding specifically for ChemistryManufacturingand ControlCMCof scale up production of long acting atrial natriuretic peptidedANPand its protected graft co polymerPGCexcipient for use in heart failureHFtreatmentThe extrinsic merit of this project will be the availability of cGMP grade PGC for use in prolonging the half life of various peptide drugs that are in p ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
PREDICTIVE BIOMARKERS OF ADVERSE REACTIONS TO PROSTRATE CANCER RADIOTHERAPY
SBC: L2 DIAGNOSTICS LLC Topic: NCIThe overall objective of this project is to advance the development of a clinically usefully multiplex assay todetect biomarkers of radio sensitivity that will identify subsets of prostate cancer patients for whichradiotherapy should be contraindicated This assay will be capable of predicting the risk of developingadverse effects principally urinary morbidity and rectal injury resulting from ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
A Novel Tolerance Therapeutic for Treating Multiple Sclerosis
SBC: VIRTICI LLC Topic: NIAIDOur goal is to develop VTC MSas a novel tolerance inducing therapeutic to treat Multiple SclerosisMSMS is the most common demyelinating disorder of the Central Nervous SystemCNSaffecting approximatelymillion people worldwide andin the US aloneCurrent and developing treatment of MS relies mainly on immuno suppression and modulation to reduce inflammatory symptoms creating a significant need for new ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Development of an Open Speech Signal Processing Platform
SBC: SensorLogic, Inc. Topic: NIDCDThis proposal will create an open speech signal processing platform. The open computational framework will be used for developing algorithms that will help accelerate acoustic and hearing science research. It will permit researchers to more rapidly and easily test new algorithms with greater control, performance, and ease. Several example systems will be created to show that the platform can be ad ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
A Novel Peptide Therapeutic for Obesity
SBC: VIRTICI LLC Topic: 300Project Summary The goal of this project is to develop a novel peptide therapeuticVTC Gfor the treatment of obesityTodayone third of adults in the United StatesUSare obesewith an estimated annual healthcare burden of approximately $billionByit is projected that overof adults in the US will be obese with a yearly healthcare burden expected to exceed $billionwhich will account for approximatelyof th ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Practical high resolution microscopy of un-cut, un-embedded lung biopsies
SBC: APPLIKATE TECHNOLOGIES, INC. Topic: NCIProject Summary and Relevance The aim of this Phase II SBIR proposal from Applikate TechnologiesLLCis to build on the successful completion of our Phase I milestones with the designconstructionand testing of prototype devices and software for implementing the ClearView tissue histology system in clinical settings by laboratory personnelClearView is a novel approach to performing complete and non d ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health